Table 2.
Pharmacokinetic parameters of sildenafil citrate reported in different ethnic groups after a single oral administration of a 100-mg or 50-mg tablet.
Ethnic Group |
n | Age (years) |
Dose (mg) |
(ng/ml) |
(h) |
(ng.h/ml) |
(ng.h/ml) |
(h) |
CL/F | MRT (h) | Ref. | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Mexican | 29 | 30.2 | 100 mg (1 tab) | 765.9 | 0.85 | 1873.3 (t = 24 h) | 1894.6 | 4.12 | 352.56 | 60.3 | 3.68 | (Marcelín-Jiménez et al., 2012) |
Mexican | 30 | 24.4 | 100 mg (1 tab) | 657.64 | 1.42 | 1884.97 (t = 16 h) | 1983.03 | 3.06 | — | — | 3.86* | (Valenzuela et al., 2011) |
Mexican | 24 | — | 100 mg (1 tab) | 1044 | 1.2 | 2960 (t = 12 h) | — | 4.3 | — | — | 6.2 | (Flores-Murrieta et al., 2000) |
Iranian | 11 | — | 100 mg (2x50 mg tabs) | 840.0 | 1.13 | 2790.0 (t = 24 h) | 2870.0 | 2.90 | — | — | 3.13* | (Mahmoudian et al., 2010) |
Thai | 15 | 28.8 | 100 mg (1 tab) | 661.54 | 0.99 | 1876.36 (t = 12 h) | — | 3.11 | — | 58.94 | 4.48 | (Kanjanawart et al., 2011) |
Caucasian | 34 | ≈ 31.5 | 100 mg (1 tab) | 514.0 | 0.95 | 1651.0 (t = 24 h) | 1670 | 3.98 | — | — | 5.88* | (Nichols et al., 2002) |
Caucasian | 27 | 28.8 | 100 mg (1 tab) | 302.0 | 3.10 | 1468 (t = 24 h) |
— | 3.48 | — | — | 5.03* | (Muirhead et al., 2000) |
Caucasian | 24 | 29 | 50 (1 tab) | 254.89 | 0.75 | — (t = 24 h) |
619.88 | 3.79 | — | — | 5.47* | (Jetter et al., 2002) |
Egyptian | 12 | 22 | 50 (1 tab) | 236.0 | 1.74 | — (t = 12 h) |
1336 | 2.39 | 134.9 | 40.1 | 2.97* | (Hedaya et al., 2005) |
Egyptian | 10 | ≈ 29 | 50 (1 tab) | 318.35 | 1.25 | — (t = 12 h) |
484.2 | 1.92 | — | — | 2.63* | (Hegazy 2014) |
Jordanian | 6 | 30 | 50 (1 tab) | 212.4 | 1.25 | 515.4 (t = 24 h) |
564.5 | 1.73 | — | — | 2.50* | (Al-Ghazawi et al., 2010) |
Cmax maximum plasma concentration; Tmax time to maximum plasma concentration; AUC0-t area under the plasma concentration–time curve up to the last measurable concentration; AUC0-∞ area under the plasma concentration–time curve up to time infinity; t1/2 the half-life; Vss/F apparent volume of distribution at steady state; CL/F apparent clearance; MRT mean residence time.
Estimated from references as (MRT = half-life/0.693).